- Assays and cell lines -

B’SYS is a specialty provider for cardiac safety studies and CiPA - Comprehensive in vitro Proarrhythmia Assays
Member of the "CiPA Ion-Channel Work-Group" (FDA/HESI CiPA initiative)

• 15 years’ experience in conducting ion channel studies
• With our experienced team and array of capabilities we can support screening of compounds from discovery to entry-into-man / IND enabling
• Proprietary cardiac ion channel cell lines
• Cardiac safety studies on three independent automated patch clamp rigs (Sophion QPatch™)
• Ion channel trafficking studies (current density and luminescence assays)
• CiPA compliant action potential studies on iPS derived cardiomyocytes(Nanion CardioExcyte™)
• Customer oriented study design
• Assays for in Vitro Effects using Human Stem-Cell derived ventricular Myocytes (Learn more...)